Response Pharmaceuticals, Inc., has unveiled significant findings from its Phase 1b clinical trial of RDX-002, signaling a potential breakthrough in combatting antipsychotic-induced weight gain (AIWG).
Response Pharmaceuticals, Inc., has unveiled significant findings from its Phase 1b clinical trial of RDX-002, signaling a potential breakthrough in combatting antipsychotic-induced weight gain (AIWG).
US Healthcare Advertising Market Advancements Highlighted by Overview, Industry Growth Rate, Research Report 2024-2032 whatech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from whatech.com Daily Mail and Mail on Sunday newspapers.
Molecure S.A., a leading biotechnology company focused on drug discovery and development, has unveiled its annual report for 2023 at the start of the new financial year.